Kion Group (FRA:KGX) PT Set at €66.00 by JPMorgan Chase & Co. - Defense World

2022-08-20 12:10:40 By : Mr. Noah Hsiang

Posted by admin on Jul 31st, 2022

Kion Group (FRA:KGX – Get Rating) received a €66.00 ($67.35) price objective from JPMorgan Chase & Co. in a research report issued on Friday, Borsen Zeitung reports. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 48.82% from the stock’s previous close.

KGX has been the subject of several other research reports. The Goldman Sachs Group set a €40.00 ($40.82) target price on Kion Group in a research report on Friday, July 8th. Sanford C. Bernstein set a €29.00 ($29.59) price target on Kion Group in a research note on Thursday. Hauck and Aufhaeuser set a €89.00 ($90.82) price target on Kion Group in a research note on Friday, April 29th. Hauck Aufhäuser In… set a €81.00 ($82.65) price target on Kion Group in a research note on Thursday, June 30th. Finally, Warburg Research set a €66.00 ($67.35) price target on Kion Group in a research note on Tuesday, June 28th.

FRA:KGX opened at €44.35 ($45.26) on Friday. Kion Group has a 12-month low of €57.87 ($59.05) and a 12-month high of €81.82 ($83.49). The stock has a 50-day moving average price of €42.60 and a 200 day moving average price of €58.91.

KION GROUP AG provides industrial trucks, warehouse technology, supply chain solutions, and related services worldwide. The company operates through Industrial Trucks & Services, and Supply Chain Solutions segments. It develops, manufactures, and sells forklift and warehouse trucks, such as counterbalance trucks with electric drive and internal combustion engine, ride-on and hand-operated industrial trucks, and towing vehicles under the Linde, Fenwick, STILL, Baoli, and OM brand names.

Receive News & Ratings for Kion Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kion Group and related companies with MarketBeat.com's FREE daily email newsletter.

Brokerages Set Teva Pharmaceutical Industries Limited (NYSE:TEVA) PT at $10.17

Xos, Inc. (NASDAQ:XOS) Receives $6.95 Consensus Price Target from Brokerages